Figma shows strong growth, profitability, and global traction ahead of its IPO, but founder control and valuation risks ...

Halfway into 2025, the capital raised in U.S.-listed IPOs has already reached 73% of 2024's full-year volume, according to ...

The design-software firm has drawn up plans to go public 18 months after competition authorities erased its $20 bln sale to ...

For companies that have gone public in 2025, the market has sent a clear message: The big winners are the biggest companies. Two of this year's marquee debutants — Circle (CRCL) and CoreWeave (CRWV), ...

A high adenoma detection rate (ADR) is vital for effective colorectal cancer (CRC) screening, but evidence suggests limited additional benefit beyond a certain threshold. In a pooled analysis of five ...